Ensuring Global Access to Cancer Medicines: A Generational Call to Action

Dare AJ 1 , Bayle A 2 , Hatoqai A 3 , Mungo C 4 , Velilla DG 5 , Soto-Perez-de-Celis E 6 Show all authors , Gnangnon FHR 7 , Lim MSH 8 , Ralefala T 9 , Mushininga VD 10

Affiliations 

  • 1 Department of Surgery, University of Toronto, Toronto, Ontario, Canada
  • 2 Oncostat U1018, Inserm, Paris-Saclay University, Gustave Roussy, Villejuif, France
  • 3 Cancer Control Office, King Hussein Cancer Center, Amman, Jordan
  • 4 Department of Obstetrics and Gynecology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
  • 5 Departamento de Oncología Radiante, Instituto Nacional del Cáncer (INCAN), Capiatá, Paraguay
  • 6 Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico
  • 7 Department of Visceral Surgery, National Teaching Hospital-Hubert Koutoukou Maga, CNHU-HKM, Cotonou, Benin
  • 8 Department of Paraclinical Sciences, Faculty of Medicine and Health Sciences, University Malaysia Sarawak (UNIMAS), Sarawak, Malaysia
  • 9 Princess Marina Hospital, Ministry of Health and Wellness, Gaborone, Botswana
  • 10 Ministry of Health and Child Care, Harare, Zimbabwe
Cancer Discov, 2023 Feb 06;13(2):269-274.
PMID: 36734325 DOI: 10.1158/2159-8290.CD-22-1372

Abstract

Essential cancer treatments are not accessible, affordable, or available to patients who need them in many parts of the world. A new Access to Oncology Medicines (ATOM) Coalition, using public-private partnerships, aims to bring essential cancer medicines and diagnostics to patients in low- and lower middle-income countries.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications